BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11297164)

  • 1. Pseudohypoparathyroidism type IA and II with severe neuropsychic manifestations.
    Kutílek S; Kabícek P; Nedvídková J; Bayer M
    Turk J Pediatr; 2001; 43(1):70-5. PubMed ID: 11297164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of pseudohypoparathyroidism in adolescent boys.
    Kabícek P; Kutílek S; Bayer M; Stĕpán JJ
    Acta Univ Carol Med (Praha); 1994; 40(1-4):53-6. PubMed ID: 9355673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case of pseudohypoparathyroidism type 1b diagnosed as having hypocalcemia].
    Iida S
    Clin Calcium; 2005 Apr; 15(4):689-93. PubMed ID: 15802786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract.
    Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A
    J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Separation of pseudohypoparathyroidism into types I and II using only basal nephrogenous cAMP determinations.
    Singhellakis P; Pappas A; Nicolou CH; Ikkos D
    Endocrinologie; 1991; 29(1-2):67-71. PubMed ID: 1666440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism.
    Ish-Shalom S; Rao LG; Levine MA; Fraser D; Kooh SW; Josse RG; McBroom R; Wong MM; Murray TM
    J Bone Miner Res; 1996 Jan; 11(1):8-14. PubMed ID: 8770691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Late onset epilepsy as the first symptom of pseudohypoparathyroidism].
    Villarreal-Núñez F; Adames-Quintero AE; Noriega L
    Rev Neurol; 2005 Aug 1-15; 41(3):155-8. PubMed ID: 16047299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohypoparathyroidism: report of seven cases.
    Chen YJ; Shu SG; Chi CS
    Acta Paediatr Taiwan; 2005; 46(6):374-80. PubMed ID: 16640041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pseudohypoparathyroidism type Ia patient with normocalcemia.
    Tamada Y; Kanda S; Suzuki H; Tajima T; Nishiyama T
    Endocr J; 2008 Mar; 55(1):169-73. PubMed ID: 18250541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical heterogeneity of pseudohypoparathyroidism: from hyper- to hypocalcemia.
    Shalitin S; Davidovits M; Lazar L; Weintrob N
    Horm Res; 2008; 70(3):137-44. PubMed ID: 18663313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parathyroid insufficiency syndrome. Two new cases: type Ia pseudohypoparathyroidism and pseudo-idiopathic hypoparathyroidism].
    Barajas de Frutos D; Pedrero Vera J; Bolívar Barrales JE; Espigares Martín R; Ortega Martos L; Vílchez Joya R; Bolívar Galiano V; Morell Bernabé JJ
    An Esp Pediatr; 1989 Oct; 31(4):385-8. PubMed ID: 2560613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid.
    Unluturk U; Harmanci A; Babaoglu M; Yasar U; Varli K; Bastepe M; Bayraktar M
    Am J Med Sci; 2008 Jul; 336(1):84-90. PubMed ID: 18626245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malleus head fixation: association with pseudohypoparathyroidism.
    LaRouere MJ; Coleman G; Telian SA; Kemink JL
    Am J Otol; 1990 Sep; 11(5):354-6. PubMed ID: 2240180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased urinary phosphate excretion in pseudohypoparathyroidism type II with long-term treatment with phosphodiesterase inhibitor.
    Mano T; Uchimura K; Hayashi R; Kobahashi T; Fujiwara K; Makino M; Kakizawa H; Nagata M; Nakai A; Wada M; Nagasaka A; Itoh M
    Horm Metab Res; 1999 Nov; 31(11):602-5. PubMed ID: 10598827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pseudohypoparathyroidism type 1 with systemic lupus erythematosus].
    Hara K; Suzuki T; Imai F; Tanaka M; Ohno S; Matuo H
    Ryumachi; 1989 Jun; 29(3):200-6. PubMed ID: 2814708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis of hypoparathyroidism and the Ellsworth-Howard's test].
    Okazaki R
    Clin Calcium; 2007 Aug; 17(8):1182-5. PubMed ID: 17660613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of pseudohypoparathyroidism Type I & Type II (author's transl)].
    Yamada K; Tamura Y; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1976 Oct; 52(10):983-96. PubMed ID: 190053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pseudohypoparathyroidism].
    Yamamoto M; Akatsu T
    Nihon Rinsho; 1995 Apr; 53(4):991-7. PubMed ID: 7752498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standard procedure and the diagnostic criteria for the Ellsworth-Howard test using human PTH-(1-34)].
    Ogata E; Yamamoto M; Matsumoto T; Fujita T; Fukase M; Kinoshita Y; Furukawa Y; Sohn HE; Nakajima H; Yasuda T
    Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):971-84. PubMed ID: 6096181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.